CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop ‘variant-proof’ COVID-19 vaccine Read more
IIT Madras-designed trial shows efficacy of Indomethacin drug in treating hospitalised mild and moderate COVID-19 patients Read more